• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Acute influence of different beta-blocking agents upon left heart hemodynamics at rest and during exercise in patients with coronary artery disease.

作者信息

Reale A, Nigri A, Gioffrè P A, Motolese M

出版信息

Eur J Cardiol. 1979 Feb;9(2):101-9.

PMID:32041
Abstract

The study investigated the acute hemodynamic changes induced in patients with angiographically confirmed coronary artery disease by 3 beta-blockers: metoprolol, cardioselective without intrinsic sympathomimetic activity (ISA), group I, 11 patients; bunitrolol, noncardioselective with ISA, group II, 11 patients; oxprenolol, noncardioselective with ISA, group III, 11 patients. Hemodynamic variables were obtained at rest and during exercise, before and 45 min after 10 mg i.v. of the drug. Changes in LVEDP and cardiac indexes were such as LV function was improved in 1 patient of group I, 7 patients of group II and 5 patients of group III; impaired in 4 patients of group I and in 1 patient of group III; unchanged in the others. Contractility indexes were less influenced by bunitrolol and oxprenolol. During exercise there was a significant difference between groups for LVEDP which was lower in group II (P less than 0.01). The data seem to indicate that the choice of the beta-blocker may be of importance when it is desirable that an already compromised cardiac function be not further impaired by pharmacological intervention.

摘要

相似文献

1
Acute influence of different beta-blocking agents upon left heart hemodynamics at rest and during exercise in patients with coronary artery disease.
Eur J Cardiol. 1979 Feb;9(2):101-9.
2
Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?冠心病中的静脉β受体阻滞剂:心脏选择性或内在拟交感活性在血流动力学上是否有用?
N Engl J Med. 1982 Mar 18;306(11):631-5. doi: 10.1056/NEJM198203183061102.
3
Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease.阿替洛尔与环丙洛尔对冠心病心脏功能的比较作用
J Cardiovasc Pharmacol. 1989 Jan;13(1):155-61.
4
[Effects of nitroglycerin on exercise hemodynamics in patients with coronary heart disease under treatment with beta-blockers (mepindolol, oxprenolol) and a calcium-antagonist (fendiline) (author's transl)].
Wien Med Wochenschr. 1980 Dec 15;130(23):772-7.
5
Relation of diastolic function and exercise capacity in ischemic left ventricular dysfunction. Role of beta-agonists and beta-antagonists.缺血性左心室功能障碍时舒张功能与运动能力的关系。β受体激动剂和β受体拮抗剂的作用。
Circulation. 1990 Aug;82(2 Suppl):I89-96.
6
[Hemodynamic effects of intravenously administered celiprolol in patient with coronary heart disease and depressed left ventricular function].
Arzneimittelforschung. 1987 Apr;37(4):444-6.
7
Comparison of hemodynamic responses to isoproterenol infusion and surgical stress in patients given cardioselective and noncardioselective beta-adrenergic antagonists.
Anesth Analg. 1987 Jul;66(7):637-42.
8
Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile.缺血性心脏病中的β受体阻滞剂——同时存在内在拟交感活性或α受体阻滞剂对血流动力学特征的影响。
Postgrad Med J. 1983;59 Suppl 3:45-52.
9
[Preoperative treatment with beta-receptor blockers and isoflurane anesthesia. Hemodynamic interactions in patients with coronary disease].
Anaesthesist. 1990 Jul;39(7):361-6.
10
Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.β-肾上腺素能受体阻断药的中心血流动力学:β1选择性与内在拟交感活性
J Cardiovasc Pharmacol. 1983;5 Suppl 1:S21-5.

引用本文的文献

1
Haemodynamic dose-response effects of i.v. metoprolol in coronary heart disease.静脉注射美托洛尔对冠心病的血流动力学剂量反应效应。
Eur J Clin Pharmacol. 1981;19(5):323-7. doi: 10.1007/BF00544581.
2
Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease.普萘洛尔和拉贝洛尔对冠心病血流动力学剂量反应的比较效应
Br Heart J. 1982 Oct;48(4):364-71. doi: 10.1136/hrt.48.4.364.
3
Initiation and maintenance of beta-blockade with intravenous oxprenolol.
Eur J Clin Pharmacol. 1983;24(1):7-14. doi: 10.1007/BF00613920.
4
Haemodynamic advantages of combined alpha-blockade and beta-blockade over beta-blockade alone in patients with coronary heart disease.在冠心病患者中,联合使用α受体阻滞剂和β受体阻滞剂相较于单独使用β受体阻滞剂的血流动力学优势。
Br Med J (Clin Res Ed). 1982 Jul 31;285(6338):325-7. doi: 10.1136/bmj.285.6338.325.
5
The effects on left ventricular performance of nifedipine and verapamil in exercise-induced angina pectoris.硝苯地平和维拉帕米对运动诱发型心绞痛患者左心室功能的影响。
Br J Clin Pharmacol. 1984 Jun;17(6):735-43. doi: 10.1111/j.1365-2125.1984.tb02411.x.
6
Systolic time intervals during long-term beta-blockade with alprenol in ischaemic heart disease.缺血性心脏病患者长期使用阿普洛尔进行β受体阻滞剂治疗期间的收缩期时间间期
Eur J Clin Pharmacol. 1983;25(4):503-6. doi: 10.1007/BF00542118.
7
Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease.冠心病患者静脉注射普萘洛尔与吲哚洛尔的血流动力学剂量反应比较效应
Eur J Clin Pharmacol. 1983;25(2):157-65. doi: 10.1007/BF00543785.
8
Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.β受体阻滞剂的部分激动剂活性在严重心绞痛中的作用:吲哚洛尔与阿替洛尔的双盲比较。
Br Med J (Clin Res Ed). 1984 Oct 13;289(6450):951-3. doi: 10.1136/bmj.289.6450.951.
9
How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.内在拟交感活性如何调节对β-肾上腺素能受体拮抗剂的血流动力学反应。其降压机制本质的一个线索。
Br J Clin Pharmacol. 1982;13(Suppl 2):245S-257S. doi: 10.1111/j.1365-2125.1982.tb01922.x.
10
Plasma catecholamines, plasma renin activity and haemodynamics during sodium nitroprusside-induced hypotension and additional beta-blockage with bunitrolol.硝普钠诱导低血压期间及联合布尼洛尔额外β受体阻滞时的血浆儿茶酚胺、血浆肾素活性及血流动力学
Eur J Clin Pharmacol. 1981;19(5):317-22. doi: 10.1007/BF00544580.